New Zealand bans synthetic drugs
WELLINGTON, New Zealand – New Zealand on Thursday, May 8, banned synthetic drugs after Prime Minister John Key conceded an attempt to regulate the market in so-called "legal highs" had failed.
The sale of products such as synthetic cannabis and legal "party pills," which mimic the effects of drugs like ecstasy, were banned after the government introduced legislation this week following protests from the families of users affected by the substances.
"All psychoactive products will become unapproved from Thursday and it will be an offence to possess, supply or sell them," Health Minister Tony Ryall said.
Under the legislation, supply or manufacture of the drugs can result in a two-year jail term or fine of up to NZ$500,000 ($433,000).
The law represents a shift in New Zealand's approach to synthetic drugs after it moved to restrict access to them last year without banning them altogether.
Instead, the government allowed about 40 products deemed to be safe by health officials to remain on the market while all other synthetic drugs were declared illegal until their producers could provide clinical proof that they were not harmful.
But families of users, including teenagers, argued the psychoactive drugs still on sale were not safe and Key, who faces an election later this year, admitted the policy had been a mistake.
"In hindsight, we probably should have taken the ultra-conservative view and said no, we'll get rid of the whole lot in one go," he told reporters after announcing the ban. – Rappler.com
Image of pills from Shutterstock
We keep you informed because you matter
We tell you the stories that matter. We ask, we probe, we explain.
But as we strive to do all this and speak truth to power, we face constant threats to our independence.
Help us make a difference through free and fearless journalism. With your help, you enable us to keep providing you with our brand of compelling and investigative work.
Joining Rappler PLUS allows us to build communities of action with you. PLUS members will receive our editorial newsletters and industry reports, get to join exclusive online conversations with our award-winning journalists, and be part of our monthly events.
Make your move now. Join Rappler PLUS.